Dear Mr. Zaffran, Dear All,
I am very pleased to get in touch with you. Actually, It is my first participation in the TECHNET21. Regarding the names, I suggest "controlled temperature storage and transportation". It will be controlled since the temperature is monitored as I understand. "Ambient" is not a good idea since some references define ambient temperature with the range from 20 to 25 degree C. I think the other terms may have false implications of non controlled storage. This was what exactly happend with me when I first read about "out of cold chain". I thought that the cold chain was failed and the product was spoiled. "Flexible cold chain" is not appropriate from my point of view since it is no more cold.
Kind regards, Mohamed Mohamed Refaat MohamedInspector Pharmacist, Biological Products InspectorateCentral Administration for Pharmaceutical Affairs, Ministry of Health21 Abdel-Aziz Al-Soaad St., Manial Al-RoddaCairo, 11451 - EgyptTel: ++202 2368 4381 - ++202 2368 4288Fax: ++202 2368 4194Mobile: ++2 012 04 08 258E-mail: [email protected]
The issues are to be looked differently. The longevity of the thermostable vaccine v/s routine vaccines that can survive higher temperatures and being effective for say 30 days, etc. In field practice some thing else happens - the most dangerous thawing - frequent heating and cooling which destroys the vaccine in a shorter period. Temperatures exposed at various places could be different. So temperature recommendations prescribed are optimal ones and shelf-life is described. What is probably discussed as I understand is the stability despite some amount of thawing that could protect the vaccine. Nagaraj
I thought that the term "cool chain" used by the optimize group was excellent. Not necessarily cold, but still cool.
- Page :
- 1